SABCS 2024 | The role of molecular tumor boards in breast cancer care

Name: The role of molecular tumor boards in breast cancer care
Uploaded: 2024-12-13T00:00:00Z
Duration: 1 min 52 s

Jenna Canzoniero • 13 Dec 2024

SABCS 2024

Breast Cancer

Jenna Canzoniero, MD, Johns Hopkins Sidney Kimmel Cancer Center, Baltimore, MD, explores the critical role of molecular tumor boards (MTB) in guiding oncologists through complex molecular diagnostics in breast cancer treatment. Medical oncologists, molecular pathologists, researchers, and patient advocates are all involved in developing personalized treatment strategies. MTBs interpret advanced genetic reports, integrating insights from multi-gene panels, and whole exome sequencing results. This interview took place at the 2024 San Antonio Breast Cancer Symposium (SABCS) congress in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.